Lymphatics in the liver
肝脏中的淋巴管
基本信息
- 批准号:10391056
- 负责人:
- 金额:$ 62.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAblationAreaAscitesCarbon TetrachlorideCellsCirrhosisDataDevelopmentDiseaseDisease ProgressionFatty acid glycerol estersFibronectinsFluid BalanceFluorescence MicroscopyFunctional disorderGoalsHealthHepaticHepatic FibrogenesisHepatocyteImmunologic SurveillanceInflammationInflammatory ResponseInhalationIntegrinsKDR geneKupffer CellsLigationLightLiverLiver FibrosisLymphLymphangiogenesisLymphaticLymphatic Endothelial CellsLymphatic SystemModelingMusNerveNervous system structureNeurotransmittersOperative Surgical ProceduresOrganPatientsPhenotypePhysiologyPlayPortal HypertensionPortal vein structurePreventionPreventive treatmentProductionRegulationResearchRoleSchwann CellsSignal TransductionSiteSourceSurgical ModelsTestingTherapeuticTissuesVascular Endothelial Growth Factor CVascular Endothelial Growth Factor Receptor-3absorptionbile ductliver developmentlymphatic vesselmacrophageoverexpressionrecruitresponsesingle-cell RNA sequencingspatiotemporaltreatment effectvascular contributionsvessel regression
项目摘要
SUMMARY
The lymphatic system maintains tissue fluid homeostasis and regulates local inflammatory
responses.1,2 The liver lymphatic system remains poorly understood. The goal of this proposed research is to
advance our understanding of the mechanisms of hepatic lymphangiogenesis (the formation of new lymphatic
vessels) and the role of lymphatic vessels in liver pathophysiology.
Vascular endothelial growth factor C (VEGF-C) is the major inducer of lymphangiogenesis. Our
preliminary studies have shown that enhanced hepatic lymphangiogenesis by VEGF-C overexpression
reduces liver fibrosis, suggesting a therapeutic potential. Additional data show that Schwann cells of hepatic
sympathetic nerves play a central role in hepatic lymphangiogenesis as a source of VEGF-C and as a recruiter
of macrophages, which may contribute to hepatic lymphangiogenesis by producing fibronectin-1 (FN1), a
substrate for integrins essential for VEGF-C/VEGF receptor 3 (VEGFR3) signaling. We thus hypothesize that
lymphatic ablation should increase inflammation and promote disease progression, and lymphangiogenesis
driven by Schwann cells and macrophages through VEGF-C signaling should alleviate inflammation and inhibit
disease progression. To test these hypotheses, we propose the following Specific Aims:
1. Determine the Schwann cell-driven mechanisms that promote hepatic lymphangiogenesis.
2. Determine Kupffer cells/macrophages-driven mechanisms that promote hepatic lymphangiogenesis.
3. Determine the role of lymphangiogenesis in the development of liver fibrosis.
The proposed research will elucidate the regulation of lymphatic vessels visually and mechanistically
and their functional importance in liver fibrosis/cirrhosis. Further, the potential of VEGF-C overexpression and
subsequent induction of lymphangiogenesis for the prevention and treatment of liver fibrosis/cirrhosis as well
as portal hypertension and ascites will be evaluated. Furthermore, this research will significantly contribute to
the advancement of the study of the liver by exploring relatively underexamined areas of the hepatic lymphatic
system and nervous system.
概括
淋巴系统维持组织液稳态并调节局部炎症
反应。1,2 对肝脏淋巴系统的了解仍知之甚少。这项研究的目标是
增进我们对肝淋巴管生成机制(新淋巴管的形成)的理解
血管)和淋巴管在肝脏病理生理学中的作用。
血管内皮生长因子 C (VEGF-C) 是淋巴管生成的主要诱导剂。我们的
初步研究表明,VEGF-C 过表达可增强肝淋巴管生成
减少肝纤维化,表明具有治疗潜力。额外的数据表明,肝雪旺细胞
交感神经作为 VEGF-C 的来源和招募者,在肝淋巴管生成中发挥核心作用
巨噬细胞可能通过产生纤连蛋白-1 (FN1) 来促进肝淋巴管生成,纤连蛋白-1
VEGF-C/VEGF 受体 3 (VEGFR3) 信号传导所必需的整合素的底物。因此我们假设
淋巴消融会增加炎症并促进疾病进展和淋巴管生成
由雪旺细胞和巨噬细胞通过 VEGF-C 信号传导驱动,应能减轻炎症并抑制
疾病进展。为了检验这些假设,我们提出以下具体目标:
1. 确定雪旺细胞驱动的促进肝淋巴管生成的机制。
2. 确定库普弗细胞/巨噬细胞驱动的促进肝淋巴管生成的机制。
3.确定淋巴管生成在肝纤维化发展中的作用。
拟议的研究将从视觉和机械角度阐明淋巴管的调节
及其在肝纤维化/肝硬化中的功能重要性。此外,VEGF-C 过度表达和
随后诱导淋巴管生成,以预防和治疗肝纤维化/肝硬化
将评估门脉高压和腹水。此外,这项研究将显着有助于
通过探索肝淋巴管相对未被充分检查的区域来推进肝脏研究
系统和神经系统。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YASUKO IWAKIRI其他文献
YASUKO IWAKIRI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YASUKO IWAKIRI', 18)}}的其他基金
Hepatic lymphatics in alcohol-associated liver disease
酒精相关性肝病中的肝淋巴管
- 批准号:
10824029 - 财政年份:2023
- 资助金额:
$ 62.17万 - 项目类别:
Endotheliopathy and liver injury in COVID-19
COVID-19 中的内皮病和肝损伤
- 批准号:
10468220 - 财政年份:2021
- 资助金额:
$ 62.17万 - 项目类别:
Endotheliopathy and liver injury in COVID-19
COVID-19 中的内皮病和肝损伤
- 批准号:
10662455 - 财政年份:2021
- 资助金额:
$ 62.17万 - 项目类别:
Endotheliopathy and liver injury in COVID-19
COVID-19 中的内皮病和肝损伤
- 批准号:
10319358 - 财政年份:2021
- 资助金额:
$ 62.17万 - 项目类别:
The role of Kupffer cells in alcohol-induced liver disease
库普弗细胞在酒精性肝病中的作用
- 批准号:
9761401 - 财政年份:2017
- 资助金额:
$ 62.17万 - 项目类别:
Mechanisms of Alcohol-Induced Hepatic Osteodystrophy
酒精性肝性骨营养不良的机制
- 批准号:
8969937 - 财政年份:2016
- 资助金额:
$ 62.17万 - 项目类别:
Mechanisms of Alcohol-Induced Hepatic Osteodystrophy
酒精性肝性骨营养不良的机制
- 批准号:
9326892 - 财政年份:2016
- 资助金额:
$ 62.17万 - 项目类别:
相似海外基金
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 62.17万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
心房細動に対するPulsed Field Ablationの組織創傷治癒過程を明らかにする網羅的研究
阐明房颤脉冲场消融组织伤口愈合过程的综合研究
- 批准号:
24K11201 - 财政年份:2024
- 资助金额:
$ 62.17万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
遅延造影心臓MRIによる心房細動Ablation冷却効果の比較:28 vs. 31 mm Cryoballoon
使用延迟对比增强心脏 MRI 比较房颤消融冷却效果:28 毫米与 31 毫米 Cryoballoon
- 批准号:
24K11281 - 财政年份:2024
- 资助金额:
$ 62.17万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
InSPACE-VT_Development and Validation of Virtual Pace Mapping to Guide Catheter Ablation of Ventricular Tachycardia
InSPACE-VT_虚拟起搏测绘的开发和验证以指导室性心动过速导管消融
- 批准号:
EP/Z001145/1 - 财政年份:2024
- 资助金额:
$ 62.17万 - 项目类别:
Fellowship
CAREER: Heat Penetration Depth and Direction Control with Closed-Loop Device for Precision Ablation
职业:利用闭环装置控制热穿透深度和方向,实现精确烧蚀
- 批准号:
2338890 - 财政年份:2024
- 资助金额:
$ 62.17万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334777 - 财政年份:2024
- 资助金额:
$ 62.17万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334775 - 财政年份:2024
- 资助金额:
$ 62.17万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334776 - 财政年份:2024
- 资助金额:
$ 62.17万 - 项目类别:
Continuing Grant
Cryo laser-ablation system (157+193nm) with 'triple-quad' plasma mass spectrometer, Cryo-LA-ICPMS/MS
带有“三重四极杆”等离子体质谱仪、Cryo-LA-ICPMS/MS 的冷冻激光烧蚀系统 (157 193nm)
- 批准号:
515081333 - 财政年份:2023
- 资助金额:
$ 62.17万 - 项目类别:
Major Research Instrumentation
MRI: Acquisition of a Laser Ablation - Inductively Coupled Plasma - Triple Quadrupole - Mass Spectrometer (LA-ICP-QQQ-MS) System For Research and Education
MRI:获取用于研究和教育的激光烧蚀 - 电感耦合等离子体 - 三重四极杆 - 质谱仪 (LA-ICP-MS/MS) 系统
- 批准号:
2320040 - 财政年份:2023
- 资助金额:
$ 62.17万 - 项目类别:
Standard Grant